查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494809

到 2030 年心血管和软组织修復贴片市场预测：按产品类型、材料类型、应用、最终用户和地区进行的全球分析

Cardiovascular & Soft Tissue Repair Patch Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球心血管和软组织修復补片市场规模将达到 50 亿美元，预计在预测期内将以 10.1% 的复合年增长率增长，到 2030 年达到 90 亿美元。

心血管和软组织修復补片是外科手术中用于修復心血管系统受损或衰弱组织或体内软组织的医疗设备。这些贴片通常由与人体自然癒合过程相容的生物相容性材料製成，例如合成聚合物或生物组织。在心血管手术中，这些补片通常用于修復心臟壁缺陷，例如间隔缺陷或先天性心臟缺陷，或增强血管薄弱区域，例如动脉瘤或动脉切开术。

根据PubMed Central 2021 年8 月发表的一篇论文，对沙乌地阿拉伯的500 名参与者进行了一项横断面研究，腹部疝气的盛行率为38.8%，18-25 岁参与者中的盛行率为21.2%。

心血管疾病和软组织损伤的盛行率上升

由于老化、生活方式改变和遗传倾向等因素，包括心臟病和先天性心臟疾病在内的心血管疾病变得越来越常见，增加了对有效手术介入的需求。同样，由于体力活动增加和创伤等因素，疝气和腹壁缺损等软组织损伤的发生率也在增加。此类需要手术修復的疾病的激增正在推动对高级修復补丁的需求。这些补片为加强或替换受损组织、提高手术效果和患者康復以及推动市场成长提供了可靠的解决方案。

手术费用上升

由于开发和製造过程中涉及先进的材料和技术，先进的医疗设备通常需要大量成本。因此，使用这些贴片进行手术的总费用可能会让许多患者望而却步，尤其是那些保险不足或医疗资金有限的地区的患者。因此，与这些手术相关的经济挑战阻碍了心血管和软组织修復补片市场的广泛采用和成长。

材料科学与技术的进展

生物工程组织、合成聚合物和奈米材料等生物相容性材料的创新促进了更有效、更耐用和多功能修復贴片的开发。这些尖端材料提高了贴片与自然组织融合的能力，降低了排斥风险并增强了整体癒合过程。此外，技术的进步使得能够创建具有特殊功能的贴片，例如药物释放型特性，可以将药物直接输送到修復部位以防止感染并促进癒合，从而使心血管和软组织修復贴片成为可能，这导致了越来越普及。

严格的监管要求

FDA 和 EMA 等监管机构对安全性、有效性和品质制定了严格的标准，并要求进行广泛的临床测试和记录。这导致製造商的开发时间更长，成本更高。製造商必须投入大量资源来满足这些严格的标准。因此，严格的监管要求可能会限制新的和改进的心血管和软组织修復补片的供应，阻碍市场成长并延迟患者获得最先进治疗。

COVID-19 的影响

最初，针对 COVID-19 病例的封锁和资源分配导致选择性手术减少，包括那些需要修復修补程式的手术。结果，市场成长暂时下降。然而，随着医疗保健系统的调整，手术恢復，市场復苏。对卫生的关注也可能鼓励了无菌贴片的采用。总体而言，在暂时的挫折之后，在心血管疾病盛行率上升和贴片技术进步的推动下，市场预计将恢復到疫情前的成长轨迹。

预计心臟补片细分市场在预测期内将是最大的

由于心臟补片常用于微创心血管手术，预计心臟补片在预测期内将达到最大值。这种微创方法是心血管治疗的主要趋势，而心臟贴片在促进这一过程中发挥重要作用。随着微创手术普及，对心臟贴片的需求预计将会增加。此外，有效的心臟补片可以促进组织再生、改善心臟功能并减少併发症。这可以改善患者的治疗效果，从而提高外科医生的采用率，并增加对这些贴片的需求。

血管修復与重组领域预计在预测期内复合年增长率最高

血管修復和重组领域预计在预测期内复合年增长率最高，因为它需要能够承受血流压力的坚固、耐用和生物相容性补片。这将推动补片材料的创新，并专注于血管应用的特定功能。此外，它还包括从动脉瘤治疗到周边动脉疾病的各种手术。特定应用需要不同类型的补丁，从而为不同的补丁技术创造了多样化的市场。

比最大的地区

由于心臟疾病患病率上升、製药公司大量存在、研发费用增加以及疝气疾病发生率增加，预计北美将在预测期内占据最大的市场占有率。例如，根据美国7 月疾病管制与预防中心的资料，心臟病是美国的主要原因之一。冠心病是所有心臟病中最常见的心臟病，在美国约有2010万20岁以上的成年人患有冠心病，推动了该地区的市场成长。

复合年增长率最高的地区：

医疗基础设施的快速发展、微创手术的成长趋势、心臟疾病盛行率的上升、医疗旅游的增加、中国和印度等多个国家的经济快速扩张、老年人口的增加以及慢性病负担的增加。方面，预计亚太地区在预测期内将保持最高的复合年增长率，并预计在未来几年内实现最快的成长率。此外，人们对先天性心臟疾病早期诊断、检测和及时治疗重要性的认识不断提高，也正在推动市场的发展。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球心血管和软组织修復贴片市场：按产品类型

  • 血管补片
  • 心臟贴片
  • 整形外科修復补片
  • 硬脑膜修补补片
  • 疝气修补片
  • 乳房重建补片
  • 其他产品类型

第六章全球心血管和软组织修復贴片市场：依材料类型

  • 生物补丁
    • 异种移植
    • 同种异体移植
  • 合成补丁
    • 聚四氟乙烯 (PTFE)
    • 聚酯纤维
    • 聚丙烯
    • 其他合成补丁

第七章全球心血管和软组织修復贴片市场：按应用分类

  • 血管修復与重组
  • 动脉瘤修復
  • 心包修復术
  • 硬脑膜修復
  • 软组织修復
  • 心臟修復
    • 先天性心臟疾病
    • 阀门维修
  • 其他用途

第八章全球心血管和软组织修復贴片市场：按最终用户分类

  • 日间手术中心 (ASC)
  • 医院
  • 专科诊所
  • 研究/学术机构
  • 其他最终用户

第九章全球心血管和软组织修復贴片市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Abbott
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • Glycar SA Pty Ltd.
  • Integra LifeSciences Corporation
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Neovasc
  • Novomedics
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.
Product Code: SMRC26324

According to Stratistics MRC, the Global Cardiovascular & Soft Tissue Repair Patch Market is accounted for $5.0 billion in 2024 and is expected to reach $9.0 billion by 2030 growing at a CAGR of 10.1% during the forecast period. Cardiovascular and Soft Tissue Repair Patches are medical devices used in surgical procedures to repair damaged or weakened tissues in the cardiovascular system or soft tissues elsewhere in the body. These patches are typically made from biocompatible materials, such as synthetic polymers or biological tissues, that are compatible with the body's natural healing processes. In cardiovascular surgeries, these patches are commonly used to repair defects in the heart's walls, such as septal defects or congenital heart defects, or to reinforce weakened areas of blood vessels, such as aneurysms or arteriotomies.

According to the article published by PubMed Central in August 2021, a cross-sectional study was performed on 500 participants in Saudi Arabia, which showed that the prevalence of abdominal hernia was 38.8 percent and the participants in 18-25 years had less prevalence of 21.2 percent.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular disease and soft tissue injuries

Cardiovascular diseases, including heart attacks and congenital heart defects, becoming increasingly common due to factors like aging populations, lifestyle changes, and genetic predispositions, there is a growing demand for effective surgical interventions. Similarly, the incidence of soft tissue injuries, such as hernias and abdominal wall defects, is on the rise due to factors like increased physical activity and trauma. This surge in medical conditions requiring surgical repair boosts the demand for advanced repair patches. These patches offer reliable solutions for reinforcing or replacing damaged tissues, enhancing surgical outcomes and patient recovery driving the markets growth.

Restraint:

High cost of procedures

Advanced medical devices often come with substantial costs due to the sophisticated materials and technologies involved in their development and manufacturing. Consequently, the overall expense of surgical procedures using these patches can be prohibitive for many patients, particularly those without adequate health insurance coverage or in regions with limited healthcare funding. Therefore, the financial challenges associated with these procedures hinder the widespread adoption and growth of the cardiovascular and soft tissue repair patch market.

Opportunity:

Advancements in material science and technology

Innovations in biocompatible materials, such as bioengineered tissues, synthetic polymers, and nanomaterials, have led to the development of more effective, durable, and versatile repair patches. These cutting-edge materials improve the patches' ability to integrate with natural tissues, reduce the risk of rejection, and enhance the overall healing process. In addition technological advancements have also enabled the creation of patches with specialized features, such as drug-eluting properties, which can deliver medications directly to the repair site to prevent infection and promote healing leading to increased adoption and expanded use of cardiovascular and soft tissue repair patches.

Threat:

Stringent regulatory requirements

Regulatory agencies, such as the FDA and EMA, impose rigorous standards for safety, efficacy, and quality, requiring extensive clinical testing and documentation. This leads to prolonged development timelines and increased costs for manufacturers, who must invest significant resources to meet these stringent criteria. As a result, stringent regulatory requirements can limit the availability of new and improved cardiovascular and soft tissue repair patches, hindering market growth and delaying patient access to cutting-edge treatments.

Covid-19 Impact

Initially, lockdowns and resource allocation towards COVID-19 cases led to a decline in elective surgeries, including those requiring repair patches. This caused a temporary dip in market growth. However, as healthcare systems adapted, procedures resumed, and the market recovered. The focus on hygiene might have also driven aseptic patch adoption. Overall, after a temporary setback, the market is expected to return to its pre-pandemic growth trajectory, fueled by the rising prevalence of cardiovascular diseases and advancements in patch technology.

The cardiac patches segment is expected to be the largest during the forecast period

The cardiac patches is expected to be the largest during the forecast period as cardiac patches are often used in minimally invasive heart surgeries. This minimally invasive approach is a major trend in cardiovascular treatments, and cardiac patches play a key role in facilitating it. As minimally invasive procedures become more prevalent, the demand for cardiac patches is expected to rise. Moreover, effective cardiac patches can promote tissue regeneration, improve heart function, and reduce complications. This translates to better patient outcomes, leading to a higher adoption rate by surgeons and increased demand for these patches.

The vascular repair & reconstruction segment is expected to have the highest CAGR during the forecast period

The vascular repair & reconstruction segment is expected to have the highest CAGR during the forecast period because these procedures necessitate strong, durable, and biocompatible patches that can withstand the pressure of blood flow. This drives innovation in patch materials, with a focus on functionalities specifically suited for vascular applications. Further it also encompasses various procedures, from treating aneurysms to peripheral artery disease. The need for different patch types based on the specific application creates a diversified market for various patch technologies.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the rising prevalence of cardiac diseases, the presence of a large number of pharmaceutical companies, growing research and development expenditure, and increasing incidences of hernia disorders. For instance, according to data from the Centers for Disease Control and Prevention in July 2022, heart disease is one of the leading causes of death in the United States. Among all the heart diseases coronary heart disease is the most common type of heart disease and about 20.1 million adults age 20 and older have coronary heart disease in the United States drives the growth of the market in this region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period owing to rapid developments in healthcare infrastructure, growing trends of minimally invasive surgical procedures, rising incidence of cardiac disease, increasing medical tourism, rapid economic expansion in several countries such as China and India, rising geriatric population, and increasing burden of chronic disorders, Asia Pacific is expected to register the fastest growing rate in the coming years. Additionally raising awareness about the importance of early diagnosis and detection of congenital cardiac disorders, as well as quick treatment propels the market.

Key players in the market

Some of the key players in Cardiovascular & Soft Tissue Repair Patch market include Abbott, Admedus, Atriummed, B.Braun, Bard Peripheral Vascular Inc., Baxter, CorMatrix, Cryolife, Inc., Edwards Life Sciences Corporation, Glycar SA Pty Ltd., Integra LifeSciences Corporation, LabCor, LeMaitre Vascular Inc., Maverick Bioscience, Neovasc, Novomedics, Southern Lights Biomaterials, TEI Biosciences Inc., Terumo Medical Corporation and W.L. Gore & Associates, Inc.

Key Developments:

In April 2024, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit(TM) BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK).

In April 2024, Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive. The Vantive mission, Extending Lives, Expanding Possibilities, will guide and inspire the proposed company, which will focus on vital organ therapies for acute and chronic kidney diseases and beyond.

In March 2024, Abbott, and the Real Madrid Foundation announced the extension of their partnership through Real Madrid's 2026-27 season. Abbott will remain Global Health Sciences and Nutrition Partner of Real Madrid Football Club and Global Partner of the Real Madrid Foundation.

Product Types Covered:

  • Vascular Patches
  • Cardiac Patches
  • Orthopedic Repair Patches
  • Dural Repair Patches
  • Hernia Repair Patches
  • Breast Reconstruction Patches
  • Other Product Types

Material Types Covered:

  • Biologic Patches
  • Synthetic Patches

Applications Covered:

  • Vascular Repair & Reconstruction
  • Aneurysm Repair
  • Pericardial Repair
  • Dural Repair
  • Soft Tissue Repair
  • Cardiac Repair
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers (ASCs)
  • Hospitals
  • Specialty Clinics
  • Research & Academic Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cardiovascular & Soft Tissue Repair Patch Market, By Product Type

  • 5.1 Introduction
  • 5.2 Vascular Patches
  • 5.3 Cardiac Patches
  • 5.4 Orthopedic Repair Patches
  • 5.5 Dural Repair Patches
  • 5.6 Hernia Repair Patches
  • 5.7 Breast Reconstruction Patches
  • 5.8 Other Product Types

6 Global Cardiovascular & Soft Tissue Repair Patch Market, By Material Type

  • 6.1 Introduction
  • 6.2 Biologic Patches
    • 6.2.1 Xenografts
    • 6.2.2 Allografts
  • 6.3 Synthetic Patches
    • 6.3.1 Polytetrafluoroethylene (PTFE)
    • 6.3.2 Polyester
    • 6.3.3 Polypropylene
    • 6.3.4 Other Synthetic Patches

7 Global Cardiovascular & Soft Tissue Repair Patch Market, By Application

  • 7.1 Introduction
  • 7.2 Vascular Repair & Reconstruction
  • 7.3 Aneurysm Repair
  • 7.4 Pericardial Repair
  • 7.5 Dural Repair
  • 7.6 Soft Tissue Repair
  • 7.7 Cardiac Repair
    • 7.7.1 Congenital Heart Defects
    • 7.7.2 Valve Repair
  • 7.8 Other Applications

8 Global Cardiovascular & Soft Tissue Repair Patch Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers (ASCs)
  • 8.3 Hospitals
  • 8.4 Specialty Clinics
  • 8.5 Research & Academic Institutions
  • 8.6 Other End Users

9 Global Cardiovascular & Soft Tissue Repair Patch Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott
  • 11.2 Admedus
  • 11.3 Atriummed
  • 11.4 B.Braun
  • 11.5 Bard Peripheral Vascular Inc.
  • 11.6 Baxter
  • 11.7 CorMatrix
  • 11.8 Cryolife, Inc.
  • 11.9 Edwards Life Sciences Corporation
  • 11.10 Glycar SA Pty Ltd.
  • 11.11 Integra LifeSciences Corporation
  • 11.12 LabCor
  • 11.13 LeMaitre Vascular Inc.
  • 11.14 Maverick Bioscience
  • 11.15 Neovasc
  • 11.16 Novomedics
  • 11.17 Southern Lights Biomaterials
  • 11.18 TEI Biosciences Inc.
  • 11.19 Terumo Medical Corporation
  • 11.20 W.L. Gore & Associates, Inc.

List of Tables

  • Table 1 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Vascular Patches (2021-2030) ($MN)
  • Table 4 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Cardiac Patches (2021-2030) ($MN)
  • Table 5 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Orthopedic Repair Patches (2021-2030) ($MN)
  • Table 6 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Dural Repair Patches (2021-2030) ($MN)
  • Table 7 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Hernia Repair Patches (2021-2030) ($MN)
  • Table 8 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Breast Reconstruction Patches (2021-2030) ($MN)
  • Table 9 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 10 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 11 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Biologic Patches (2021-2030) ($MN)
  • Table 12 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Xenografts (2021-2030) ($MN)
  • Table 13 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Allografts (2021-2030) ($MN)
  • Table 14 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Synthetic Patches (2021-2030) ($MN)
  • Table 15 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polytetrafluoroethylene (PTFE) (2021-2030) ($MN)
  • Table 16 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polyester (2021-2030) ($MN)
  • Table 17 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polypropylene (2021-2030) ($MN)
  • Table 18 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Synthetic Patches (2021-2030) ($MN)
  • Table 19 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Application (2021-2030) ($MN)
  • Table 20 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Vascular Repair & Reconstruction (2021-2030) ($MN)
  • Table 21 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Aneurysm Repair (2021-2030) ($MN)
  • Table 22 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Pericardial Repair (2021-2030) ($MN)
  • Table 23 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Dural Repair (2021-2030) ($MN)
  • Table 24 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Soft Tissue Repair (2021-2030) ($MN)
  • Table 25 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Cardiac Repair (2021-2030) ($MN)
  • Table 26 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 27 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Valve Repair (2021-2030) ($MN)
  • Table 28 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Ambulatory Surgical Centers (ASCs) (2021-2030) ($MN)
  • Table 31 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 32 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 33 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Research & Academic Institutions (2021-2030) ($MN)
  • Table 34 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.